We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » The AI Revolution – Webinar Recording/Transcript

Other Options

USB Audio Recording/Transcript - Sept. 25, 2019

$287.00

USB Audio Recording/Transcript - Sept. 25, 2019

$258.00

USB Audio Recording/Transcript - Sept. 25, 2019

$244.00

USB Audio Recording/Transcript - Sept. 25, 2019

$230.00

USB Audio Recording/Transcript - Sept. 25, 2019

$215.00
webinar recording

The AI Revolution – Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

The AI Revolution: What You Must Know About Medical Imaging Regulation

AI is changing the face of image analysis — allowing complex patterns in medical images to be identified to a greater degree than ever before. Specific conditions can be identified… quantified… independently diagnosed… or ruled out entirely. With this comes the possibility of over-reliance on technology — potentially reducing vigilance with standard of care.

How will the FDA keep pace with the evolving nature of these technologies while still ensuring that their safety and effectiveness are maintained? While there are still many issues the agency must work through, you need an understanding now of the FDA’s approaches to AI-based image analysis.

As both a physician and a lawyer, John J. Smith, M.D., J.D, a partner at Hogan Lovells, is uniquely suited to explain what you need to know about the FDA’s AI regulation in this 90-minute presentation.

Presentation Takeaways:

  • How FDA views AI within its medical device regulatory paradigm
  • The different types of computer-assisted image analysis recognized by FDA
  • The data that FDA expects to support AI-based CAD applications
  • How FDA views post-market changes to CAD algorithms

You will understand the new regulatory framework FDA is developing so that you can determine how to best incorporate AI into your devices and software.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing